We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genencor to Commercialize Decontamination Technology

By Biotechdaily staff writers
Posted on 02 Mar 2004
An exclusive license to manufacture and sell enzymes to decontaminate certain organophosphate-based nerve agents such as sarin has been granted to Genencor (Palo Alto, CA, USA) by the U.S. More...
Army Edgewood Chemical Biological Center (ECBC, Aberdeen Proving Ground, MD, USA).

Genencor plans to scale up and manufacture the enzymes that can be added to water and dispensed in foams, sprays, or detergents. The enzymes will be made available to military and civilian first responders, such as firefighters, police, and hazardous material response teams. The enzymes neutralize the chemical agents and have the benefit of being noncorrosive and environmentally friendly.

"This government-industry partnership demonstrates how the tools of biotechnology can be used to address important problems facing society,” said Jean-Jacques Bienaime, chairman and chief executive officer of Genencor. The company is a diversified biotechnology company that develops and delivers innovative products and services into the health care, agri-processing, consumer, and industrial markets.




Related Links:
Genencor
Edgewood Chemical Biological Center

New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Electrolyte Analyzer
BKE-B
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.